Journal of Clinical Pediatrics >
Clinical features, treatments, and outcomes of neonatal arrhythmia
Received date: 2022-03-07
Online published: 2023-07-05
Objective To evaluate the etiology, treatment and outcome of neonatal arrhythmia. Methods The clinical data and short-term follow-up results of neonates diagnosed with arrhythmia from June 2017 to May 2020 were retrospectively analyzed. Results Twenty-three cases with neonatal arrhythmia (11 boys and 12 girls) were included. The mean gestational age was (36.2±2.9) weeks and the mean birth weight was (2784.8±727.7) grams. There were 12 full-term and 11 preterm infants. Abnormal fetal heart rhythm of 8 cases were observed in the prenatal period. There were 9 cases of ectopic beats, 12 cases of tachycardia and 2 cases of conduction block. The main causes of arrhythmia were cardiac structural abnormality, neonatal respiratory distress syndrome and asphyxia at birth. Fourteen cases did not have clear etiology or clinical symptoms. Twelve cases with tachycardia were treated with anti-arrhythmia drugs or electrical cardioversion, while those without clinical symptoms (6 cases of supraventricular premature beats, 3 cases of ventricular premature beats and 1 case of atrioventricular block) did not receive anti-arrhythmia therapy. Four neonates died (17.4%) eventually. Serum levels of creatine kinase, creatine kinase-MB isoenzyme, cardiac troponin T and B-type natriuretic peptide in death group were significantly higher than those in survival group, and the difference was statistically significant (P<0.05). Of the 19 infants who survived until discharge, 11 showed abnormal rhythm on dynamic electrocardiogram, and 2 were treated with oral anti-arrhythmia drug after discharge. By 1 year of age, none of the patients had been readmitted to the hospital for symptomatic arrhythmia. Conclusions Arrhythmia may occur in newborns with underlying diseases, or without clear cause or clinical symptoms. The prognosis of patients with elevated myocardial markers is poor. Rapid arrhythmia should be considered as soon as possible. For those without clear cause or symptoms, those with good heart function, no intervention should be involved, but need to be closely followed.
Key words: arrhythmia; cardioversion; monitoring; newborn
Wenwen CHEN , Shuzhen DAI , Liping XU . Clinical features, treatments, and outcomes of neonatal arrhythmia[J]. Journal of Clinical Pediatrics, 2023 , 41(7) : 507 -513 . DOI: 10.12372/jcp.2023.22e0320
[1] | Ran L, Li J, Bao L, et al. Association between neonatal arrhythmia and mortality and recurrence: a retrospective study[J]. Front Pediatr, 2022, 10: 818164. |
[2] | 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 5版. 北京: 人民卫生出版社, 2019. |
[3] | Chow LT, Chow SS, Anderson RH, et al. Autonomic innervation of the human cardiac conduction system: changes from infancy to senility-an immunohistochemical and histochemical analysis[J]. Anat Rec, 2001, 264(2):169-182. |
[4] | 闫晓甜, 薄涛, 王成, 等. 新生儿非良性快速性心律失常的心率变异性研究[J]. 中国当代儿科杂志, 2019, 21(5): 474-478. |
[5] | Hylind RJ, Chandler SF, Skinner JR, et al. Genetic testing for inherited cardiac arrhythmias: current state-of-the-art and future avenues[J]. J Innov Card Rhythm Manag, 2018, 9(11): 3406-3416. |
[6] | Binneto?lu FK, Babao?lu K, Türker G, et al. Diagnosis, treatment and follow up of neonatal arrhythmias[J]. Cardiovasc J Afr, 2014, 25(2): 58-62. |
[7] | Sarquella-Brugada G, Cesar S, Zambrano MD, et al. Electrocardiographic assessment and genetic analysis in neonates: a current topic of discussion[J]. Curr Cardiol Rev, 2019, 15(1): 30-37. |
[8] | Chu PY, Hill KD, Clark RH, et al. Treatment of supraventricular tachycardia in infants: analysis of a large multicenter database[J]. Early Hum Dev, 2015, 91(6): 345-350. |
[9] | Bjelo?evi? M, Illíková V, Tomko J, et al. Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: a 10-year population-based study[J]. Pacing Clin Electrophysiol, 2020, 43(7): 680-686. |
[10] | Y?lmaz-Semerci S, Bornaun H, Kurnaz D, et al. Neonatal atrial flutter: three cases and review of the literature[J]. Turk J Pediatr, 2018, 60(3): 306-309. |
[11] | Garson A Jr, Bink-Boelkens M, Hesslein PS, et al. Atrial flutter in the young: a collaborative study of 380 cases[J]. J Am Coll Cardiol, 1985, 6(4): 871-878. |
[12] | Lisowski LA, Verheijen PM, Benatar AA, et al. Atrial flutter in the perinatal age group: diagnosis, management and outcome[J]. J Am Coll Cardiol, 2000, 35(3): 771-777. |
[13] | Valembois L, Audureau E, Takeda A, et al. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation[J]. Cochrane Database Syst Rev, 2019, 9(9): CD005049. |
[14] | Allen LA, Fonarow GC, Simon DN, et al. Digoxin use and subsequent outcomes among patients in a contemporary atrial fibrillation cohort[J]. J Am Coll Cardiol, 2015, 65(25): 2691-2698. |
[15] | Pfammatter JP, Paul T. Idiopathic ventricular tachycardia in infancy and childhood: a multicenter study on clinical profile and outcome. Working Group on Dysrhythmias and Electrophysiology of the Association for European Pediatric Cardiology[J]. J Am Coll Cardiol, 1999, 33(7): 2067-2072. |
[16] | Sossalla S, Vollmann D. Arrhythmia-induced cardio-myopathy[J]. Dtsch Arztebl Int, 2018, 115(19) : 335-341. |
[17] | El Joueid N, Touma Boulos M, Abou Jaoude S, et al. Ventricular tachycardia in an infant without congenital anomaly: a case report[J]. Cardiol Res, 2020, 11(1): 61-65. |
[18] | ?engül FS, Kafal? HC, Güzelta? A, et al. Clinical spectrum and long-term course of sustained ventricular tachycardia in pediatric patients: 10 years of experience[J]. Anatol J Cardiol, 2021, 25(5): 313-322. |
[19] | Hansahiranwadee W. Diagnosis and management of fetal autoimmune atrioventricular block[J]. Int J Womens Health, 2020, 12: 633-639. |
[20] | Baruteau AE, Pass RH, Thambo JB, et al. Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management[J]. Eur J Pediatr, 2016, 175(9): 1235-1248. |
[21] | Costa R, Silva KRD, Martinelli Filho M, et al. Minimally invasive epicardial pacemaker implantation in neonates with congenital heart block[J]. Arq Bras Cardiol, 2017, 109(4): 331-339. |
[22] | Baruteau AE, Fouchard S, Behaghel A, et al. Cha-racteristics and long-term outcome of non-immune isolated atrioventricular block diagnosed in utero or early childhood: a multicentre study[J]. Eur Heart J, 2012, 33(5): 622-629. |
[23] | Kasar T, Sayg? M, ?zy?lmaz ?, et al. Spontaneous remission of congenital complete atrioventricular block in anti-Ro/La antibody-negative monozygotic twins: case report[J]. Balkan Med J, 2017, 34(1): 71-73. |
[24] | Nakamura T, Noma S. Follow-up of isolated congenital complete atrioventricular block with longitudinal measurements of serum NT-proBNP and cardiothoracic ratio[J]. Fukushima J Med Sci, 2020, 66(1): 37-40. |
[25] | Manzoor N, Minhaj A, Akmal M. Congenital adrenal hyperplasia presenting as pulseless ventricular tachycardia in a neonate[J]. Cureus, 2019, 11(5): e4749. |
[26] | Popescu MR, Panaitescu AM, Pavel B, et al. Getting an early start in understanding perinatal asphyxia impact on the cardiovascular system[J]. Front Pediatr, 2020, 8: 68. |
[27] | Jiang L, Li Y, Zhang Z, et al. Use of high-sensitivity cardiac troponin I levels for early diagnosis of myocardial injury after neonatal asphyxia[J]. J Int Med Res, 2019, 47(7): 3234-3242. |
[28] | Mikolka P, Kosutova P, Balentova S, et al. Early cardiac injury in acute respiratory distress syndrome: comparison of two experimental models[J]. Physiol Res, 2020, 69(Suppl 3): S421-S432. |
[29] | Fernández-Morales JC, Morad M. Regulation of Ca2+ signaling by acute hypoxia and acidosis in rat neonatal cardiomyocytes[J]. J Mol Cell Cardiol, 2018, 114: 58-71. |
[30] | Daimi H, Lozano-Velasco E, Aranega A, et al. Genomic and non-genomic regulatory mechanisms of the cardiac sodium channel in cardiac arrhythmias[J]. Int J Mol Sci, 2022, 23(3): 1381. |
/
〈 |
|
〉 |